Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
GE Healthcare shows signs of life, but a lingering uncertainty keeps us on the sidelines
We're taking a nearly 300% profit on a hot drug stock — adhering to an investing rule to live by
A journey inside Epic Systems' mythical and sprawling campus, a world away from Wall Street
FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout
Element Counseling: Empowering Individuals to Embrace Authenticity and Overcome Life’s Challenges
